The North America bone densitometer market growth is anticipated to progress at a CAGR of 3.80% during the forecast period, 2022-2030, and is expected to reach a revenue of $474.37 million by 2030.

The large presence of end-users like physician practices, clinics, hospitals, etc., influences the region’s market growth. Also, the presence of prominent healthcare companies makes the region a promising market for bone densitometers.

To know more about this report, request a free sample copy

The North America bone densitometer market growth evaluation includes the assessment of Canada and the United States. In the United States, the growing bone densitometer adoption is due to the rise in orthopedic treatments, the high geriatric population, and osteoporosis. As per the American Academy of Orthopedic Surgeons, around half of the population has knee osteoarthritis. In addition, almost 10 million people are affected by osteoporosis. Also, there are increasing knee replacement surgeries in the country.

Moreover, technological advancements like ultrasonic densitometers, computer-assisted densitometers, and integrated digital detectors offer growth opportunities. Further, the vast adoption of advanced imaging technologies and the rising public awareness contribute to market growth. Additionally, the well-developed healthcare infrastructure, the high adoption rate of technologically advanced bone densitometers, and the availability of reimbursement for therapeutic and diagnostic procedures boost market growth prospects.

The North America bone densitometer market segmentation includes the evaluation of end-user, technology, and application. The market by application includes cystic fibrosis, body composition measurement, rheumatoid arthritis, and osteopenia & osteoporosis.

Cystic fibrosis (CF) is a genetic disease causing damage to the digestive system, lungs, and other organs of the body. It impacts cells that produce digestive juices, sweat, and mucus. The genetic mutation induced by CF raises the thickness of mucus, which hinders the functioning of organs like the air movement through the lungs. As a result, bacteria get trapped, leading to infections. In addition, CF enables risk factors like the development of low bone mineral density. This further results in joint diseases like arthritis, osteoporosis, joint pain, and osteopenia.

Furthermore, CF patients are at increased risk of inflammation, chronic infections, and certain lung infections. These further impact normal bone growth and maintenance, increasing the risk of osteoporosis and osteopenia.

Osteopenia occurs when bones become weaker than normal bones, but osteopenia bones do not break easily. It usually happens after 50 and occurs when the inside of bones becomes brittle from calcium loss. Whereas osteoporosis weakens bones due to less bone strength and mass. The bones become porous, thereby raising the risk of fractures, particularly in certain peripheral joints like wrists, and hip & the spinal vertebrae. Osteoporosis is a result of magnesium, vitamin D, and calcium deficiencies. Osteopenia and osteoporosis affect the health and strength of bones, and are determined through bone mineral density tests.

Some of the main market players in the North America bone densitometer market are OSI Systems Inc, Medilink, Scanflex Healthcare AB, Osteometer MediTech Inc, GE Healthcare, Medonica Co Ltd, etc.

GE Healthcare is a leading multinational medical technology and diagnostics innovator company in the US. It enables informed decisions for clinicians through applications, services, data analytics, and intelligent devices. It offers its services in over 160 countries, and has its headquarters in Chicago, the United States.

One of its important products, Lunar iDXA, offers a high degree of clinical confidence across all body types for body composition and bone health with a modern design. Also, it gives a glimpse into metabolic health, fracture risk, and bone density.

Report Synopsis:

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.